ST6GAL2 and thyroid cancer, nonmedullary, 2: Liang et al. [155] found that lncRNA HCP5 promoted follicular thyroid carcinoma (FTC) progression as a competing endogenous RNA (ceRNA) sponge for miR-22-3p, mi-186-5p, and miR-216a-5p and activated alpha-2,6-sialyltransferase 2 (ST6GAL2).